|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 20475 |
FusionGeneSummary for LYZ_DDOST |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: LYZ_DDOST | Fusion gene ID: 20475 | Hgene | Tgene | Gene symbol | LYZ | DDOST | Gene ID | 4069 | 1650 |
| Gene name | lysozyme | dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit | |
| Synonyms | LYZF1|LZM | AGER1|CDG1R|GATD6|OKSWcl45|OST|OST48|WBP1 | |
| Cytomap | 12q15 | 1p36.12 | |
| Type of gene | protein-coding | protein-coding | |
| Description | lysozyme C1,4-beta-N-acetylmuramidase Cc-type lysozymelysozyme F1 | dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunitadvanced glycation end-product receptor 1advanced glycation endproduct receptor 1dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit (non-catalytic)dolichy | |
| Modification date | 20180523 | 20180523 | |
| UniProtAcc | P61626 | P39656 | |
| Ensembl transtripts involved in fusion gene | ENST00000261267, ENST00000549690, ENST00000548839, | ENST00000602624, ENST00000375048, ENST00000415136, ENST00000477229, | |
| Fusion gene scores | * DoF score | 19 X 13 X 6=1482 | 6 X 5 X 3=90 |
| # samples | 23 | 7 | |
| ** MAII score | log2(23/1482*10)=-2.68783968136146 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(7/90*10)=-0.362570079384708 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: LYZ [Title/Abstract] AND DDOST [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | LYZ | GO:0031640 | killing of cells of other organism | 9727055 |
| Hgene | LYZ | GO:0042742 | defense response to bacterium | 21093056 |
| Hgene | LYZ | GO:0050830 | defense response to Gram-positive bacterium | 21093056 |
| Tgene | DDOST | GO:0006487 | protein N-linked glycosylation | 9642163 |
| Tgene | DDOST | GO:0034097 | response to cytokine | 9642163 |
| Tgene | DDOST | GO:0042110 | T cell activation | 9642163 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS3.1 | AW467499 | LYZ | chr12 | 69747545 | - | DDOST | chr1 | 20978613 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 3UTR-3UTR | ENST00000261267 | ENST00000602624 | LYZ | chr12 | 69747545 | - | DDOST | chr1 | 20978613 | + |
| 3UTR-3UTR | ENST00000261267 | ENST00000375048 | LYZ | chr12 | 69747545 | - | DDOST | chr1 | 20978613 | + |
| 3UTR-3UTR | ENST00000261267 | ENST00000415136 | LYZ | chr12 | 69747545 | - | DDOST | chr1 | 20978613 | + |
| 3UTR-intron | ENST00000261267 | ENST00000477229 | LYZ | chr12 | 69747545 | - | DDOST | chr1 | 20978613 | + |
| intron-3UTR | ENST00000549690 | ENST00000602624 | LYZ | chr12 | 69747545 | - | DDOST | chr1 | 20978613 | + |
| intron-3UTR | ENST00000549690 | ENST00000375048 | LYZ | chr12 | 69747545 | - | DDOST | chr1 | 20978613 | + |
| intron-3UTR | ENST00000549690 | ENST00000415136 | LYZ | chr12 | 69747545 | - | DDOST | chr1 | 20978613 | + |
| intron-intron | ENST00000549690 | ENST00000477229 | LYZ | chr12 | 69747545 | - | DDOST | chr1 | 20978613 | + |
| intron-3UTR | ENST00000548839 | ENST00000602624 | LYZ | chr12 | 69747545 | - | DDOST | chr1 | 20978613 | + |
| intron-3UTR | ENST00000548839 | ENST00000375048 | LYZ | chr12 | 69747545 | - | DDOST | chr1 | 20978613 | + |
| intron-3UTR | ENST00000548839 | ENST00000415136 | LYZ | chr12 | 69747545 | - | DDOST | chr1 | 20978613 | + |
| intron-intron | ENST00000548839 | ENST00000477229 | LYZ | chr12 | 69747545 | - | DDOST | chr1 | 20978613 | + |
Top |
FusionProtFeatures for LYZ_DDOST |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| LYZ | DDOST |
| Lysozymes have primarily a bacteriolytic function; thosein tissues and body fluids are associated with the monocyte-macrophage system and enhance the activity of immunoagents. | Essential subunit of the N-oligosaccharyl transferase(OST) complex which catalyzes the transfer of a high mannoseoligosaccharide from a lipid-linked oligosaccharide donor to anasparagine residue within an Asn-X-Ser/Thr consensus motif innascent polypeptide chains. Required for the assembly of bothSST3A- and SS3B-containing OST complexes. Required for efficientN-glycosylation. {ECO:0000250|UniProtKB:Q05052,ECO:0000269|PubMed:22467853, ECO:0000305}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for LYZ_DDOST |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for LYZ_DDOST |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for LYZ_DDOST |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for LYZ_DDOST |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | LYZ | C0268389 | Amyloidosis, familial visceral | 1 | CTD_human;UNIPROT |
| Tgene | DDOST | C3281084 | CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ir | 1 | ORPHANET;UNIPROT |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|